South Korea · Research startup
South Korea · Cellmeat
CellMEAT is a South Korean biotechnology and food technology company that focuses on cultured meat production using cell-based techniques.
Funding reportedLast round: Series A
About Cellmeat
CellMEAT is a South Korean biotechnology and food technology company that focuses on cultured meat production using cell-based techniques.
Founded in 2019 and headquartered in Gwangju, with operations in Seoul, the company aims to provide sustainable protein alternatives through cellular agriculture. CellMEAT has raised $33.6 million in funding and employs around 25 people, generating approximately $10.5 million in annual revenue. The company's primary product line, "GogiMEAT," includes cultured seafood and meat products, such as shrimp and caviar. A notable innovation is their proprietary CSF-A1, a fetal bovine serum-free cell culture medium that enhances cell growth efficiency. CellMEAT also utilizes non-animal serum-free cell culture technology and mass cell culture technology to support economic viability and scalability in production. They operate a mass production center in Seoul, furthering their commitment to sustainable food production.
What company datasets say Cellmeat raised
Funding, as reported
On a portfolio page
Investors who name them
Each firm lists Cellmeat on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
The company, in detail
What they build
Known for
biotechnology researchb2c
Built with from their website
Google WorkspaceGoogle MeetNginxGmail
- Sector
- Research
- Industry code
- NAICS 541714, 311999, SIC 2836, 2011
- Region
- Seoul
- Revenue
- 2M a year, as listed
- Full record
- Every detail in the company directory
Research in South Korea
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Cellmeat in front of investors. Or tell us what we have wrong.